4//SEC Filing
INVIVO THERAPEUTICS HOLDINGS CORP. 4
Accession 0001209191-13-058220
CIK 0001292519operating
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:47 PM ET
Size
5.5 KB
Accession
0001209191-13-058220
Insider Transaction Report
Form 4
HESS BRIAN
CHIEF SCIENCE OFFICER
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2013-12-19+75,000→ 75,000 totalExercise: $1.95Exp: 2023-12-18→ COMMON STOCK (75,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.
Documents
Issuer
INVIVO THERAPEUTICS HOLDINGS CORP.
CIK 0001292519
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001292519
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:47 PM ET
- Size
- 5.5 KB